Fool

Intentional surgery (ISRG 3.36%) Considerable challenges have been faced in the past year, especially related to tariffs. The company’s shares have lagged behind broader equities as a result, and with the trade war far from over, the medical device specialist’s near-term prospects look dim. However, psychosurgery has features that can help overcome these challenges and … Read more